Detailed price information for Nature S Sunshine (NATR-Q) from The Globe and Mail including charting and trades.

Nature’s Sunshine is upgraded to Buy, driven by robust DTC growth and effective influencer marketing. NATR exceeded 2025 guidance with $480.1M revenue and $49.4M adjusted EBITDA, signaling operational ...

CEO Kenneth Romanzi highlighted that "Nature's Sunshine delivered another terrific quarter, growing sales 5% and EBITDA at 10% and by continuing to execute against its key drivers of success, leading ...

Net sales in the second quarter increased 4% to $114.8 million compared to $110.6 million in the same year-ago quarter. Excluding the impact from foreign exchange rates, net sales in the second ...

Nature’s Sunshine Products, Inc. has announced the launch of an underwritten secondary public offering of up to 2,854,607 shares of its common stock, to be sold by Fosun Pharma USA, Inc. The proceeds ...

Nature’s Sunshine Products, Inc. misses on earnings expectations. Reported EPS is $-0.02 EPS, expectations were $0.2. Operator: Good afternoon, everyone, and thank you for participating in today’s ...

Nature’s Sunshine Products, Inc. beats earnings expectations. Reported EPS is $0.25, expectations were $0.17. Operator: Good afternoon, everyone. And thank you for participating in today’s conference ...